Dr. Tracy Lynne Skaer

Department of Pharmacotherapy, College of Pharmacy

Washington State University Health Sciences

Email: [email protected]

Qualifications

2007 UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL - Graduate Certificate, Center for Mindfulness in Medicine, Health Care, and Society – Sabbatical Leave, Summer Intensive Practicum, in Mindfulness-Based Stress Reduction

2001 UNIVERSITY OF SOUTH CAROLINA -Graduate Certificate, Financial Management, Moore Graduate School of Business

2000 UNIVERSITY OF CALIFORNIA AT LOS ANGELES - Graduate Certificate, Women's Leadership Institute, Anderson Graduate School of Business

1998 CORNELL UNIVERSITY - Graduate Certificate, Administrative Management Institute for Higher Education, Johnson Graduate School of Business

1990 UNIVERSITY OF SOUTHERN CALIFORNIA - Doctor of Pharmacy (Summa Cum Laude)

1985 WASHINGTON STATE UNIVERSITY - Bachelor of Pharmacy

1982 SPOKANE FALLS COMMUNITY COLLEGE - Associate of Arts

Publications (Selected)

1. Skaer, T. L., & Kwong, W. J. (2017). Illness perceptions and burden of disease in fibromyalgia. Expert Review of Pharmacoeconomics & Outcomes Research, 17(1), 9-15.
2. Smith, C., Skaer, T., Orr, M., Barbosa-Leiker, C., Howell, D., & Dyck, D. (2017). Development of multi-family group and mindfulness treatment for chronic pain: preliminary outcomes. J Musculoskelet Disord Treat, 3, 042.
3. Skaer, T. L., & Nwude, A. C. (2016). Opioid Prescribing Laws and Emergency Department Guidelines for Chronic Non‐Cancer Pain in Washington State. Pain Practice, 16(5), 642-647.
4. Skaer, L. T. (2016). Treatment recommendations for fibromyalgia. Int J Pharma Res Rev, 5(4), 19-28.
5. Skaer, T. L. (2015). Research findings using mindfulness-based interventions for chronic pain. Pain Studies and Treatment, 3(04), 38-45.
6. Skaer, T., Nwude, A., & Ervik, A. M. (2015). (440) State of Washington opoioid prescription guidelines for the management of chronic non-cancer pain. The Journal of Pain, 16(4), S86.
7. Leonard, J., Skaer, T. L., & Garrison, M. W. (2014). Can Flush and Lock Solutions Used in Human Medicine Be Applied to Large Animal IV Therapy: A Systematic Review. Journal of Equine Veterinary Science, 34(7), 837-841.
8. Skaer, T. L. (2014). Fibromyalgia: disease synopsis, medication cost effectiveness and economic burden. Pharmacoeconomics, 32(5), 457-466.
9. Skaer, T. L. (2014). Dosing considerations with transdermal formulations of fentanyl and buprenorphine for the treatment of cancer pain. Journal of Pain Research, 495-503.
10. Skaer, T. L. (2013). Sleep deprivation and economic burden. In Sleep Deprivation and Disease: Effects on the Body, Brain and Behavior (pp. 269-279). New York, NY: Springer New York.
11. Sclar, D. A., Evans, M. A., Robison, L. M., & Skaer, T. L. (2012). α1-Proteinase inhibitor (human) in the treatment of hereditary emphysema secondary to α1-antitrypsin deficiency: number and costs of years of life gained. Clinical drug investigation, 32(5), 353-360.
12. Sclar, D. A., Robison, L. M., Castillo, L. V., Schmidt, J. M., Bowen, K. A., Oganov, A. M., Skaer, T. L.,... & Kogut, S. J. (2012). Concomitant use of triptan, and SSRI or SNRI after the US Food and Drug Administration alert on serotonin syndrome. Headache: The Journal of Head and Face Pain, 52(2), 198-203.
13. Skaer, T. L., & Sclar, D. A. (2010). Economic implications of sleep disorders. Pharmacoeconomics, 28(11), 1015-1023.
14. Willson, M. N., Neumiller, J. J., Sclar, D. A., Robison, L. M., & Skaer, T. L. (2010). Ethnicity/race, use of pharmacotherapy, scope of physician-ordered cholesterol screening, and provision of diet/nutrition or exercise counseling during US office-based visits by patients with hyperlipidemia. American Journal of Cardiovascular Drugs, 10(2), 105-108.

Profile Details

https://tarc.wsu.edu/tracy-skaer/

https://scholar.google.com/citations?user=cCE3a7YAAAAJ&hl=en

WoS Researcher ID: ELN-5922-2022